Physiopathology and genetics in aspirin-exacerbated respiratory disease

References

• Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68:975–983.
   PubMed Web of Science ®Google Scholar
• Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res. 2011;3:3–10.
   PubMed Web of Science ®Google Scholar
• Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434.
   PubMed Web of Science ®Google Scholar
• Wang XS, Wu AYY, Leung PS, Lau HYA. PGE2 suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease. Allergy Eur J Allergy Clin Immunol. 2007;62:620–627.
   Web of Science ®Google Scholar
• Sanchez-Borges M. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med Clin North Am. 2010;94:853–864.
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol. 1977;60:276–284.
   PubMed Web of Science ®Google Scholar
• Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol. 2006;533:145–155.
   PubMed Web of Science ®Google Scholar
• Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet (London, England). 1997;350:1599–1600.
   PubMed Web of Science ®Google Scholar
• Van Sambeek R, Stevenson DD, Baldasaro M, Lam BK, Zhao J, Yoshida S, et al. 5′ Flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol. 2000;106:72–76.
   PubMed Web of Science ®Google Scholar
• Arima H, Aguilera G. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors. J Neuroendocrinol. 2000;12:833–842.
   PubMed Web of Science ®Google Scholar
• Kawagishi Y, Mita H, Taniguchi M, Maruyama M, Oosaki R, Higashi N, et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol. 2002;109:936–942.
   PubMed Web of Science ®Google Scholar
• Choi JH, Park HS, Oh HB, Lee JH, Suh YJ, Park CS, et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet. 114;337–344.
   PubMed Web of Science ®Google Scholar
• Kim SH, Bae JS, Suh CH, Nahm DH, Holloway JW, Park HS. Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness. Allergy Eur J Allergy Clin Immunol. 2005;60:760–765.
   Web of Science ®Google Scholar
• Capra V. Molecular and functional aspects of human cysteinyl leukotriene receptors. Pharmacol Res. 2004;50:1–11.
   PubMed Web of Science ®Google Scholar
• Park JS, Chang HS, Park CS, Lee JH, Lee YM, Choi JH, et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet. Genomics. 15, 2005;483–492.
   PubMed Web of Science ®Google Scholar
• Lee EH, Park BL, Park SM, Lee SH, Park SW, Park JS, et al. Association analysis of RGS7BP gene polymorphisms with aspirin intolerance in asthmatic patients. Ann Allergy Asthma Immunol. 2011;106:292–300.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, Parameswaran KN, Watson RM, O'Byrne PM. Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med. 2001;164:1495–1500.
   PubMed Web of Science ®Google Scholar
• Payne SC, Early SB, Huyett P, Han JK, Borish L, Steinke JW. Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope. 2011;121;2262–2267.
   PubMed Web of Science ®Google Scholar
• Losol P, Kim SH, Shin YS, Ye YM, Park HS. A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease. Exp Mol Med. 2013;45:e14.
   PubMed Web of Science ®Google Scholar
• Murakami M, Nakashima K, Kamei D, Masuda S, Ishikawa Y, Ishii T, et al. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem. 2003;278:37937–37947.
   PubMed Web of Science ®Google Scholar
• Perez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert, C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. J Allergy Clin Immunol. 2005;115:1189–1196.
   PubMed Web of Science ®Google Scholar
• Jinnai N, Sakagami T, Sekigawa T, Kakihara M, Nakajima T, Yoshida K, et al. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet. 2004;13:3203–3217.
   PubMed Web of Science ®Google Scholar
• Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135:245–252.
   PubMed Web of Science ®Google Scholar
• Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, Park HS. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy. 2010;65:338–346.
   PubMed Web of Science ®Google Scholar
• Kohyama K, Hashimoto M, Abe S, Kodaira K, Yukawa T, Hozawa S, et al. Thromboxane A 2 receptor +795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells -466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease. Mol Med Rep. 2012;5:477–482.
   Google Scholar
• Machado-Carvalho L, Martín M, Torres R, Gabasa M, Alobid I, Mullol J, et al. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1??/IL-1 type i receptor/COX-2 pathway: vicious circle in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137;99–107.e7.
   PubMed Web of Science ®Google Scholar
• Otto BA, Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg. 2008;16:270–274.
   PubMed Web of Science ®Google Scholar
• Erbek SS, Yurtcu E, Erbek S, Atac FB, Sahin FI, Cakmak O. Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposis. Arch Otolaryngol Head Neck Surg. 2007;133:705–709.
   PubMedGoogle Scholar
• Falfán-Valencia R, Pavón-Romero GF, Camarena A, García M de L, Galicia-Negrete G, Negrete-García MC, et al. The IL1B-511 polymorphism (rs16944 AA Genotype) is increased in aspirin-exacerbated respiratory disease in mexican population. J Allergy. 2012;2012:1–5.
   Google Scholar
• Buchheit KM, Cahill KN, Katz HR, Murphy KC, Feng C, Lee-Sarwar K, et al. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137:1566–1576e5.
   PubMed Web of Science ®Google Scholar
• Kohyama K, Abe S, Kodaira K, Yukawa T, Hozawa S, Sagara H, et al. IL-13 and IL-17A gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2011;107:510–516.
   PubMed Web of Science ®Google Scholar
• Park JS, Park BL, Kim MO, Heo JS, Jung JS, Bae DJ, et al. Association of single nucleotide polymorphisms on Interleukin 17 receptor A (IL17RA) gene with aspirin hypersensitivity in asthmatics. Hum Immunol. 2013;74:598–606.
   PubMed Web of Science ®Google Scholar
• Kim TH, Chang HS, Park SM, Nam BY, Park JS, Rhim T, et al. Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy. 2008;38:1727–1737.
   PubMed Web of Science ®Google Scholar
• Kim SH, Bae JS, Holloway JW, Lee JT, Suh CH, Nahm DH, et al. A polymorphism of MS4A2 (− 109T >C) encoding the beta-chain of the high-affinity immunoglobulin E receptor (FcepsilonR1beta) is associated with a susceptibility to aspirin-intolerant asthma. Clin Exp Allergy. 2006;36:877–883.
   PubMed Web of Science ®Google Scholar
• Kohyama K, Abe S, Kodaira K, Yukawa T, Hozawa S, Morioka J, et al. Polymorphisms of the CYP2C19 gene in Japanese patients with aspirin-exacerbated respiratory disease. J Allergy Clin. Immunol. 2011;128:1117–1120.
   PubMed Web of Science ®Google Scholar
• Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med. 2000;162:75–80.
   PubMed Web of Science ®Google Scholar
• Kohyama K, Abe S, Kodaira K, Yukawa T, Hozawa S, Morioka J, et al. Arg16Gly beta2-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol. 2011;156:405–411.
   PubMed Web of Science ®Google Scholar
• Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:9–14.
   PubMed Web of Science ®Google Scholar
• Theron AJ, Steel HC, Tintinger GR, Gravett CM, Anderson R, Feldman C. Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res. 2014;608930:1–16.
   Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111:180–186.
   PubMed Web of Science ®Google Scholar
• Katial RK, Strand M, Prasertsuntarasai T, Leung R, Zheng W, Alam R. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J Allergy Clin Immunol. 2010;126:738–744.
   PubMed Web of Science ®Google Scholar
• Esmaeilzadeh H, Nabavi M, Aryan Z, Akbar A. Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases ; HLA-DQB302. Expert Rev Respir Med. 2015;9:511–518.
   PubMed Web of Science ®Google Scholar
• Cheng CY, Su SC, Chen CH, Chen WL, Deng ST, Chung WH. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review. J Immunol Res. 2014;2014:565320.
   PubMed Web of Science ®Google Scholar
• Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope. 2000;110:422–425.
   PubMed Web of Science ®Google Scholar
• Shin SW, Park BL, Chang H, Park JS, Bae DJ, Song HJ, et al. Exonic variants associated with development of aspirin exacerbated respiratory diseases. PLoS One 2014;1–9.
   Web of Science ®Google Scholar
• Kim SH, Cho BY, Choi H, Shin ES, Ye YM, Lee JE, et al. The SNP rs3128965 of HLA-DPB1 as a genetic marker of the AERD phenotype. PLoS One 2014;9:e111220.
   PubMed Web of Science ®Google Scholar
• Esmaeilzadeh H, Nabavi M, Amirzargar AA, Aryan Z, Arshi S, Bemanian MH, et al. HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease. Am J Rhinol Allergy 2015;29:e63–e69.
   PubMed Web of Science ®Google Scholar
• Park BL, Kim TH, Kim JH, Bae JS, Pasaje CF, Cheong HS, et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet 2013;132:313–321.
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi H, Yoon MG, Ye YM, Park HS. Dipeptidyl-peptidase 10 as a genetic biomarker for the aspirin-exacerbated respiratory disease phenotype. Ann Allergy Asthma Immunol. 2015;114:208–213.
   PubMed Web of Science ®Google Scholar
• Cahill KN, Raby BA, Zhou X, Guo F, Thibault D, Baccarelli A, et al. Impaired E prostanoid2 expression and resistance to prostaglandin E2 in nasal polyp Fibroblasts from subjects with aspirin-exacerbated respiratory disease. Am J Respir Cell Mol Biol. 2016;54:34–40.
   PubMed Web of Science ®Google Scholar